Imunon, Inc.·4

Dec 11, 4:07 PM ET

Hazard Sebastien 4

4 · Imunon, Inc. · Filed Dec 11, 2023

Insider Transaction Report

Form 4
Period: 2023-12-07
Hazard Sebastien
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-12-07+20,00020,000 total
  • Award

    Stock Option (Right to Buy)

    2023-12-07+80,00080,000 total
    Exercise: $0.88Exp: 2033-12-11Common Stock (80,000 underlying)
Footnotes (2)
  • [F1]Represents grant of restricted stock, which vests on December 11, 2024.
  • [F2]Represents grant of stock option, which vests with respect to 25% of the shares on December 11, 2024, and the remaining 75% in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable on the fourth anniversary of December 11, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary